File: '\\swfile\EmailIn\20240314 165222 Attachment THC - News Release - Change of Auditor - Mar 2024 (03374289x9DEBD).DOC'

{03374289;1}

THC BIOMED INTL LTD.

P.O. Box 20033 Towne Centre

Kelowna, B.C. V1Y 9H2

www.thcbiomed.com

THC BIOMED ANNOUNCES CHANGE OF AUDITOR

THC.CSE THCBF - OTC TFHD.F

Vancouver, Canada - March 13, 2024 - THC BioMed Intl Ltd. (the "Company"), announces that the Company has changed its auditor from Baker Tilly WM LLP, Chartered Professional Accountants (the "Former Auditor") to Davidson & Company LLP, Chartered Professional Accountants (the "Successor Auditor") effective March 8, 2024. At the request of the Company, the Former Auditor resigned as auditor for the Company effective March 8, 2024, and the board of directors of the Company appointed the Successor Auditor as the replacement auditor for the Company effective March 8, 2024, until the Company's next annual general meeting.

There were no reservations in the Former Auditor's audit reports for any financial period during which the Former Auditor was the Company's auditor. There are no reportable events between the Company and the Former Auditor.

In accordance with National Instrument 51-102, the Notice of Change of Auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the Company's board of directors and will be filed on SEDAR+ accordingly.

About THC BioMed:

THC BioMed is a leading Canadian cannabis producer dedicated to delivering high-quality cannabis products to consumers nationwide. With a focus on innovation, sustainability, and customer satisfaction, THC BioMed strives to set new standards in the cannabis industry through its commitment to excellence.

For more information, contact:

John Miller, CEO THC BioMed Intl Ltd. T: 1-844-THCMEDS E: info@thcbiomed.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.